Form 4 for PRVA Privia Health Group, Inc.
Accepted 2023-05-10 00:00:00 ET · period of report 2023-05-08 · accession 0001209191-23-028495 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-05-10 | 2023-05-08 | PRVA | BERNSTEIN JEFFREY DANIEL | Dir | S - Sale | $21.62 | -24.82M | 110.3K | -100% | -$536.60M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-08 | S | D | 24,819,473 | $21.62 | 110,337 | I See footnotes | — | — | (F1) Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street Principal Investments, L.L.C., MBD 2013 Holdings L.P. and Bridge Street 2013 Holdings L.P. offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock. (F2) The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any. |